CPT code 36830 – AV graft creation for hemodialysis access

Key takeaways

CPT code 36830 reports AV access created with a nonautogenous graft, such as ePTFE, biological collagen, or a thermoplastic conduit.

Name the graft material and type in the operative note, because vague graft documentation is a common reason for audit queries and downcoding.

Medicare gives 36830 a 90-day global period and 18.18 total RVUs in 2026, or about $607 at the national conversion factor.

N18.6 for end-stage renal disease is the main diagnosis supporting medical necessity, and RT or LT shows the operative side.

Most Medicare Advantage and commercial plans require prior authorization, so confirm it is active on the date of service.

CPT code 36830 reports an AV graft for hemodialysis access

CPT code 36830 reports the surgical creation of an arteriovenous (AV) fistula using a nonautogenous graft. Put simply, the surgeon connects an artery to a vein with a manufactured tube instead of the patient’s own vessel.

Expanded PTFE (ePTFE), biological collagen, and thermoplastic conduits all qualify. A vein harvested from the patient does not, because that is an autogenous graft with its own code. Here are the reference fields to confirm before the claim goes out.

The clinical setting is almost always end-stage renal disease (ESRD), coded N18.6. These patients need permanent vascular access for dialysis, usually three times a week.

Surgeons choose a graft over a native fistula when vein mapping shows veins too small to use, or when earlier fistulas have failed. Common setups include upper arm loops, such as brachioaxillary grafts, and forearm loops. Thigh grafts are kept for patients whose arm access is exhausted.

The descriptor also labels 36830 a separate procedure. You can bill it on its own when it is the only access procedure performed. Payers bundle it when it is incidental to a larger service at the same session.

The conduit decides between 36830 and its neighbors

Codes 36818 to 36833 span AV access creation, open thrombectomy, and open revision. Picking the wrong one is a frequent compliance risk for nephrology and vascular surgery billers. The table shows where each code fits.

So the choice between 36821 and 36830 comes down to the operative note. If it names an ePTFE or other manufactured conduit, bill 36830. If the surgeon joined the patient’s own artery and vein directly, bill 36821 instead. The diagram below follows that same question across the creation codes.

A quick coding example

Say the note reads “6 mm ePTFE loop graft, left forearm, brachial artery to antecubital vein.” That supports 36830 with modifier LT, and N18.6 as the linked diagnosis.

Now picture the same note saying only “graft placed.” An auditor can’t tell an autogenous graft from a manufactured one, so expect a records request before payment.

National Correct Coding Initiative (NCCI) edits treat 36821 and 36830 as mutually exclusive for the same session. Billing both for a single access creation is a compliance violation. Check current edit pairs in the CMS NCCI Policy Manual before submission.

How a 36830 claim moves from scheduling to payment

A 36830 claim passes through five steps, and a miss at any one of them can stall payment. Here is the usual path in a surgical billing office.

1. Authorization. The front desk confirms prior authorization for Medicare Advantage and commercial plans before the surgery date.
2. Operative note. The surgeon documents the graft material, configuration, side, and why a native fistula was not possible.
3. Charge entry. The coder assigns 36830, adds RT or LT, and links N18.6 or another supporting diagnosis.
4. Submission. The claim goes to the payer through a clearinghouse, which returns rejections for missing or invalid fields.
5. Payment and follow-up. The remittance posts, and the 90-day global period starts for routine post-op care.

Most denials trace back to the first three steps. Getting them right is what makes a clean claim, one the payer can process on the first pass.

A superbill that carries the code, modifier, and linked diagnosis from the encounter also cuts retyping at charge entry. The next sections take each step in turn, starting with the operative note.

The operative note has to name the graft

Payer audits on 36830 usually start with the operative report. Vague graft-material documentation is a common reason for audit queries and downcoding. Check that each note supporting 36830 contains these elements.

• Graft material and type. Name the product and size, such as “6 mm ePTFE graft.” The phrase “synthetic graft” on its own is too vague for most auditors.
• Anatomical configuration. State the setup and side, such as “brachioaxillary loop, right upper arm.” The side must match the RT or LT modifier on the claim.
• Reason for a graft. Cite vein-mapping results showing veins too small for a native fistula, or record earlier failed autogenous attempts.
• ESRD diagnosis. Reference N18.6, or the equivalent diagnosis, in the operative header or pre-procedure assessment.
• Surgeon attestation. Confirm that the billing surgeon performed the procedure, or supervised it where delegation is allowed.

A medical billing compliance program that standardizes operative-note templates makes these elements hard to skip. A required graft-material field is the simplest place to start.

N18.6 carries medical necessity for most 36830 claims

Submitting 36830 without a diagnosis that establishes medical necessity is a frequent denial driver. These are the codes payers most often accept for the procedure. Accepted codes vary, so check payer policies and any Local Coverage Determination (LCD).

N18.6 is the primary diagnosis for 36830 in most cases. When a new graft replaces a failed fistula or graft, add an access-failure complication code, such as a vascular graft or fistula complication code. T82.49XA describes a catheter complication, so it fits only when a prior catheter problem is documented.

A vague or unrelated diagnosis, such as a hypertension code alone, is a reliable path to denial. Search the ICD-10-CM codes when you need the exact complication code for the access history.

Laterality drives most 36830 modifier decisions

Modifier selection on 36830 is a frequent source of claim rejections. The table shows when each modifier applies and the documentation that backs it.

Leaving off RT or LT, when a payer requires laterality, is a common rejection reason for 36830. Check each payer’s modifier rules at enrollment rather than discovering them at denial.

Medicare pays about $607 for 36830 in 2026

Medicare sets 36830 payment with the Resource-Based Relative Value Scale (RBRVS), and rates vary by geographic locality. The figures below are national values from the 2026 Medicare Physician Fee Schedule. Use the CMS Physician Fee Schedule look-up tool to check the rate for your MAC jurisdiction.

Both settings carry the same 18.18 total RVUs. Multiply that by the CY2026 conversion factor of about $33.40 ($33.4009) and you get roughly $607 nationally.

Your geographic practice cost index (GPCI) then adjusts that figure for your locality. For quick RVU checks without a CMS login, try the FastRVU look-up tool.

The 90-day global period bundles routine follow-up

CPT code 36830 carries a 90-day global surgical period under Medicare. During that window, the operating surgeon can’t bill these services separately.

• All routine post-operative office visits directly related to the graft creation
• Minor complications managed in the office (e.g., wound care, suture removal)
• Telephone management of expected post-operative recovery

By contrast, these services can be billed separately during the global period, as long as the correct modifier is applied.

• Modifier 24: unrelated E/M visits (e.g., the patient presents with a new problem unrelated to the graft)
• Modifier 78: return to the operating room for a complication related to the original procedure
• Modifier 79: unrelated surgical procedure during the global period

Mischaracterizing what sits inside the global package is a consistent overpayment audit finding. When in doubt, review the AAPC CPT guidance on the surgical package before billing post-op services separately.

Most commercial plans want prior authorization first

Traditional Medicare does not require prior authorization (PA) for 36830. Medicare Advantage plans and most commercial payers do, because they treat it as a non-emergent surgery. Aetna, UnitedHealthcare, Cigna, and BCBS plans commonly require PA for AV graft creation.

A complete PA request for 36830 typically includes the following elements. Leaving one out extends the review or ends in a denial.

• ESRD diagnosis (N18.6) with supporting nephrology documentation
• Evidence of failed or inadequate existing access (prior access attempt reports, thrombosis records)
• Vascular mapping results showing insufficient autologous vein caliber
• Surgeon’s written rationale for choosing a nonautogenous graft over a native fistula
• Planned anatomical site and graft material type

ESRD Network requirements may add documentation standards beyond the PA process. Confirm with the specific MAC or plan before scheduling. Then track PA status alongside the surgery date, so no case reaches the OR without approval.

Six denial triggers to catch before you submit

Denials on 36830 cluster around six failure points. A denial management routine for vascular access works like one for any high-value surgical code: document first, submit second.

1. Missing or incorrect laterality modifier. Payers require RT or LT on almost every 36830 claim. Prevention: make laterality a required field before submission.
2. No ESRD or access-failure diagnosis code. A claim without N18.6, Z99.2, or a documented access complication code fails medical-necessity review. Prevention: link the diagnosis at charge entry, not at billing.
3. Operative note lacks graft material. “Synthetic graft used,” with no product type, is a common reason for audit queries and downcoding. Prevention: use an operative note template with a mandatory graft-material field.
4. Prior authorization not obtained or expired. PA for Medicare Advantage and commercial plans must be active on the date of service, not pending. Prevention: add a PA checkpoint to pre-operative scheduling.
5. Billing 36830 and 36821 for the same session. NCCI edits treat these as mutually exclusive. Prevention: run claims through a scrubber, in your billing software or clearinghouse, that checks NCCI edit pairs.
6. Billing inside your own global period without a modifier. If the same surgeon or group operated on the patient in the past 90 days, the new claim needs modifier 78 or 79. Prevention: check recent surgical history before scheduling.

Before you submit: A 36830 checklist

Run each claim against this list. It takes a minute and catches the six triggers above.

• The operative note names the graft material, type, and size.
• The side in the note matches the RT or LT modifier.
• N18.6, or another supporting diagnosis, is linked to the 36830 line.
• Prior authorization is active on the date of service.
• No 36821 for the same access sits on the claim.
• Any open global period from the same surgeon or group has modifier 78 or 79 attached.

How Pabau keeps 36830 claims moving from charge to payment

In many vascular and nephrology practices, the 36830 claim is rebuilt by hand from the operative note. Someone retypes the codes, chases the PA number, and checks a clearinghouse portal for rejections.

Pabau, the practice management and billing platform we build, pre-fills the claim from the patient record instead. The CPT code attached to the service lands on the charge line, and ICD-10 codes come from the recorded problem list. Required fields, such as authorization numbers, must be complete before the claim can be sent.

US claims go out through the Claim.MD integration, with real-time eligibility checks and ERA posting. Pabau’s claims management software then tracks each claim to payment, so a rejected 36830 claim surfaces the day it fails.

Streamline vascular access billing with Pabau

Pabau’s claims management software helps nephrology and vascular surgery practices link diagnosis codes and submit claims to your clearinghouse for codes including CPT 36830.

Book a demo

Conclusion

A clean 36830 claim starts in the operating room. When the note names the graft, the side, and why a native fistula wasn’t an option, the code choice follows.

The trade-off is a little more structure up front. A required graft-material field and a PA check at scheduling take minutes. In return, they head off the records requests and resubmissions that hold up payment.

Start with your next five 36830 notes and check them against the list above. Book a demo to see how Pabau carries the codes from those notes onto a ready-to-send claim.

Continue your research

Coding a native fistula instead? CPT code 36821 covers direct AV anastomosis with the patient’s own vessels.

Billing the dialysis sessions that follow? CPT code 90935 covers hemodialysis with a single evaluation.

Need to understand how claims reach your payer? Medical claims clearinghouse guide explains the electronic path from charge capture to ERA.

Dealing with ERA reconciliation after 36830 payment? Electronic remittance advice (ERA) in medical billing covers how to read and post 835 remittance files.

Want to decode the rejections on your 36830 claims? Denial codes in medical billing explains the CARC codes behind common rejections.

Frequently asked questions